MET

Metlife Inc

$90.10 -1.57 (-1.71%) At close · Jul 8

Market Cap

$57.97B

643,436,779

Equibles Rating blended score · not investment advice

Overall

Buy

SellHoldBuy

Technical Strong Buy Momentum Very Strong Sentiment Neutral Fundamentals Strong Quant / Vol Low

Market backdrop VIX 16.9 · calm Equity put/call 0.86

Technical

price trend

Strong Buy

50 / 200-day cross No cross

Price vs 200-day avg +15%

above

Price vs 50-day avg +8%

above

RSI (14) 62

neutral

MACD trend Positive

52-week position 91%

near high

Volume (OBV) Confirms

volume backs price

Momentum

relative strength

Very Strong

1-month return +7%

trailing

6-month return +18%

trailing

YTD return +15%

this year

Relative strength +10%

vs S&P · 6-mo

Sentiment

smart money

Neutral

Trend (MA cross) No cross

50d $83 › 200d $79 — 50d above 200d

Institutional flow Accumulating

58 of 1,378 funds reported for Jun 30 · net +60.0K sh shares · +5 new

Insider flow Distributing

Net -$1.7M over 90 days · 100% sells

Short interest Rising

2.47% of float · ▲ +13.5% MoM · 4.6 days cover

Volume signal Normal

Volume near normal

Institution breadth Steady

1,378 holders — mid 3-yr range

Squeeze score 61

elevated · 0–100

Fundamentals

Strong

Revenue growth +9%

Y/Y

EPS growth −21%

Y/Y

Valuation P/E 17.4

in line

Buyback $3.0B

authorized

Balance sheet $1.7B

net debt

Quant / Vol

risk profile

Low

Volatility 24%

annualized · 1-yr

Max drawdown −17%

past year

ATR 2.2%

of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Up next

Next earnings call

Aug 5, 2026 Est · unconfirmed · in 4 wks

FQ3-26 quarter ends

~Sep 30, 2026 Est

Latest filing: 10-Q

filed May 7, 2026

AI Brief

TL;DR.

Bullish

Bearish

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Technicals

trend & momentum for long-term holders Strong Buy

0 · 3 · 4

50 / 200-day cross

No cross Neutral

Price vs 200-day avg

+15% Bullish

Price vs 50-day avg

+8% Bullish

RSI (14)

62 Neutral

MACD trend

Positive Bullish

52-week position

91% Bullish

Volume (OBV)

Confirms Neutral

Market signals — smart money & positioning

Bearish · 2 of 6

Trend (MA cross) No cross

50d $83 › 200d $79 — 50d above 200d

Institutional flow Accumulating

58 of 1,378 funds reported for Jun 30 · net +60.0K sh shares · +5 new

Insider flow Distributing

Net -$1.7M over 90 days · 100% sells

Short interest Rising

2.47% of float · ▲ +13.5% MoM · 4.6 days cover

Volume signal Normal

Volume near normal

Institution breadth Steady

1,378 holders — mid 3-yr range

Price context

position in its 52-week range

52-wk low $67 Now $90 · 91% 52-wk high $92

vs 200-day avg +15% vs 50-day avg +8%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from its earnings releases, calls, and filings

Metric	Latest	Period	YoY
Adjusted book value per share non-GAAP	$57.41	Q1 2026	—
Adjusted earnings per share non-GAAP	$2.42	Q1 2026	—
Asia adjusted earnings non-GAAP	$487M	Q1 2026	—
EMEA adjusted earnings non-GAAP	$110M	Q1 2026	—
Expense ratio	20.7%	Q1 2026	—
Group Benefits adjusted earnings non-GAAP	$439M	Q1 2026	—
Group Benefits adjusted PFOs non-GAAP	$6,539M	Q1 2026	—
Holding company cash and liquid assets	$3.9B	Q1 2026	—
Latin America adjusted earnings non-GAAP	$229M	Q1 2026	—
MetLife Investment Management adjusted earnings non-GAAP	$47M	Q1 2026	—
Retirement and Income Solutions adjusted earnings non-GAAP	$451M	Q1 2026	—
ROE	18.2%	Q1 2026	—
Variable investment income	$518M	Q1 2026	—

adjusted return on equity non-GAAP	17%	first quarter call	—
direct expense ratio non-GAAP	11.9%	first quarter call	—
Group Life mortality ratio	80.1%	first quarter call	—
institutional client assets under management	-1.9%	first quarter call	—
Adjusted BVPS non-GAAP	$57.07	Full Year 2025	—
Adjusted earnings non-GAAP	$1.6B	Q4 2025	—
Adjusted earnings per share, excluding total notable items non-GAAP	$2.58	Q4 2025	—
Adjusted PFOs, excluding PRT non-GAAP	$12.8B	Q4 2025	—
Adjusted ROE, excluding total notable items non-GAAP	16%	Full Year 2025	—

Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file

Versus peers

Insurance - Life — same industry group

Open screener →

Company	Mkt cap	YTD	Rev growth Y/Y	P/E	Short % shares
MET Metlife Inc this stock	$57.97B	+15.0%	+8.6%	17.4	2.5%
CILJF China Life Insurance Co Ltd	$106.28B	+7.8%	—	—	0.0%
MFC Manulife Financial Corp	$68.96B	+15.3%	—	—	0.8%
AFL Aflac Inc	$61.81B	+10.7%	-9.3%	13.9	2.1%
GWLIF Great-West Lifeco Inc.	$57.82B	+33.5%	—	—	0.3%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section

Ownership

Institutional Holders Accumulating

Holders

1,382

% held: 71.5%
Reported: 58 of 1,378
Top holder: BlackRock, Inc.

Held Float

View

Held by Funds

Fund positions

796

View

Short & Settlement

Short Interest Rising

Shares short

15.9M

Days to cover: 4.6d
Change: +1.9M sh

View

Short Volume

Short vol %

37%

As of: Jul 8, 2026

Short Total

View

Fails to Deliver

FTD shares

48.1K

Value: $4.1M
As of: Jun 11, 2026

View

Off-Exchange

Off-exchange %

42.4%

Week of: Jun 15, 2026

Off-exch Lit

View

Smart Money

Insider Trades Net selling

Net (90d)

-$1.7M

Buyers / Sellers: 0 / 1

Buyers Sellers

View

Congressional Trades Sell

Member

Gilbert Cisneros

Amount: $1.0K–$15.0K
Traded: Aug 6, 2025

View

Financials

Revenue (FY)

$77.1B

Net income (FY): $3.4B
EPS diluted: $4.71

View

Buybacks

Authorized

$3.0B

Remaining: $0

Spent Remaining

View

Filings

SEC Filings

Latest

8-K

Filed: Jun 29, 2026
This year: 14

View

Proposed Sales

Value

$1.7M

Shares: 21.3K
Filed: Jun 1, 2026

View

Earnings & Events

Earnings Calls

Last call

Jun 10, 2026

View

Investor Relations

Performance

	5D	20D	120D	MTD	YTD
MET	+6.5%	+6.8%	+17.7%	+6.5%	+15.0%
SPY	+0.9%	+1.4%	+7.6%	+0.1%	+9.7%
vs SPY	+5.6%	+5.4%	+10.2%	+6.4%	+5.3%

Capital returns

Latest dividend

$0.593 / share · ex May 12, 2026

Raised 4.4%

Paid (TTM)

$2.297 / share · 4 payouts

Dividend yield (TTM, derived)

2.55%

Buyback program · as of Mar 31, 2026

Authorized

$3.00B

Spent (derived)

$3.00B

Remaining

Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1099219 CUSIP 59156R108 13F (30d) 90 filings 64 filers Visit website Investor relations

MET

Price & Indicators

Technicals

Key metrics

Versus peers

At a glance

Performance

Capital returns